The 2009 Mediterranean Games silver medallist Halima Hachlaf has been banned by Athletics Integrity Unit (AIU) for doping violations.
The 33 year-old has been given six years for a second violation which is a violation of the World Athletics Anti-Doping Rules.
On 23 January 2014, the Fédération Royal Marocaine d’Athlétisme (“FRMA”) Disciplinary Commission issued a decision confirming that the Athlete had committed an anti-doping rule violation under Rule 32.2(b) (Use of a Prohibited Substance or a Prohibited Method) of the IAAF Anti-Doping Rules based on an Adverse Passport Finding in relation to her Athlete Biological Passport and that a period of ineligibility of four (4) years from 19 December 2013 was imposed.
The second doping violation happened on 17 January 2021, when the Athlete provided a urine Sample, In-Competition, at the ‘4ème Meeting Fédéral’ held in Rabat, Morocco.
On 10 February 2021, the World Anti-Doping Agency (“WADA”) accredited laboratory in Lausanne, Switzerland (the “Laboratory”) reported an Adverse Analytical Finding in the Sample for the presence of Methylprednisolone (the “Adverse Analytical Finding”).
Methylprednisolone is a Prohibited Substance according to the WADA 2021 Prohibited List under the category S9. Glucocorticoids. It is a Specified Substance prohibited In-Competition when administered by oral, intravenous, intramuscular or rectal routes.
The Moroccan received the hefty penalty after failing to respond to the charge given to her by the set deadline leaving the AIU with no option but to ban her for six (6) years for a second anti-doping rule violation under the ADR.
